Two Different Regimens of Misoprostol in Retained Placenta

Summary

This study evaluates intra umbilical vein injection of 800 µg versus 400 µg misoprostol for the treatment of retained placenta to reduce the need of manual removal of placenta under general anaesthesia

Timeline

Start

2016-03

Primary completion

2019-02-01

Completion

2019-02-14

Publications

• Kumar N, Jahanfar S, Haas DM, Weeks AD. Umbilical vein injection for management of retained placenta. Cochrane Database Syst Rev. 2021 Mar 11;3(3):CD001337. doi: 10.1002/14651858.CD001337.pub3.

Drugs

Indications